These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19255602)

  • 21. Sleep disorders in polycystic ovary syndrome: influence of obesity and hyperandrogenism.
    Hachul H; Polesel DN; Tock L; Carneiro G; Pereira AZ; Zanella MT; Tufik S; Togeiro SM
    Rev Assoc Med Bras (1992); 2019 Mar; 65(3):375-383. PubMed ID: 30994836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS.
    Zheng SH; Li XL
    Gynecol Endocrinol; 2016; 32(3):177-83. PubMed ID: 26502288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
    Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
    Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obstructive sleep apnea predisposes to nonalcoholic Fatty liver disease in patients with polycystic ovary syndrome.
    Tock L; Carneiro G; Togeiro SM; Hachul H; Pereira AZ; Tufik S; Zanella MT
    Endocr Pract; 2014 Mar; 20(3):244-51. PubMed ID: 24246334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice patterns of screening for sleep apnea in physicians treating PCOS patients.
    Subramanian S; Desai A; Joshipura M; Surani S
    Sleep Breath; 2007 Dec; 11(4):233-7. PubMed ID: 17541663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.
    Fernandez RC; Moore VM; Van Ryswyk EM; Varcoe TJ; Rodgers RJ; March WA; Moran LJ; Avery JC; McEvoy RD; Davies MJ
    Nat Sci Sleep; 2018; 10():45-64. PubMed ID: 29440941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of developing obstructive sleep apnea among women with polycystic ovarian syndrome: a nationwide longitudinal follow-up study.
    Lin TY; Lin PY; Su TP; Li CT; Lin WC; Chang WH; Chen TJ; Bai YM; Chen MH
    Sleep Med; 2017 Aug; 36():165-169. PubMed ID: 28599952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep disturbances in a community-based sample of women with polycystic ovary syndrome.
    Moran LJ; March WA; Whitrow MJ; Giles LC; Davies MJ; Moore VM
    Hum Reprod; 2015 Feb; 30(2):466-72. PubMed ID: 25432918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
    Sirmans SM; Parish RC; Blake S; Wang X
    J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep disturbances in women with polycystic ovary syndrome.
    Franik G; Krysta K; Madej P; Gimlewicz-Pięta B; Oślizło B; Trukawka J; Olszanecka-Glinianowicz M
    Gynecol Endocrinol; 2016 Dec; 32(12):1014-1017. PubMed ID: 27348625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes.
    Ortiz-Flores AE; Luque-Ramírez M; Escobar-Morreale HF
    Expert Opin Pharmacother; 2018 Dec; 19(17):1915-1926. PubMed ID: 30289728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the PCOS phenotype with age.
    Hsu MI
    Steroids; 2013 Aug; 78(8):761-6. PubMed ID: 23624031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.